Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

Between 2002 and 2004, Pfizer explored green chemistry as a product, process, and strategy design approach that could address a growing set of market complexities. The case requires students to understand and analyze how and why green chemistry might contribute to corporate growth. The case elaborates on the conditions encouraging pharmaceutical companies to engage more actively on environmental and health issues as an area of opportunity as opposed to an effort toward compliance or response to competitive threat.

About

Abstract

Between 2002 and 2004, Pfizer explored green chemistry as a product, process, and strategy design approach that could address a growing set of market complexities. The case requires students to understand and analyze how and why green chemistry might contribute to corporate growth. The case elaborates on the conditions encouraging pharmaceutical companies to engage more actively on environmental and health issues as an area of opportunity as opposed to an effort toward compliance or response to competitive threat.

Settings


Related